Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Czechia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20081
20101
20133
20144
20152
20165
20172
20191
20202
20212
20221
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated8
Recruiting3
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S4
Bristol-Myers Squibb3
Axovant Sciences Ltd.2
FORUM Pharmaceuticals Inc2
GlaxoSmithKline2
Hoffmann-La Roche2
Pfizer2
ACADIA Pharmaceuticals Inc.1
AZTherapies, Inc.1
Alzheon Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease30
Dementia9
Amyloid Neuropathies, Familial3
Amyloidosis3
Cognitive Dysfunction3
Psychomotor Agitation3
Memory Disorders2
Brain Diseases1
Cardiomyopathies1
Central Nervous System Diseases1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.